MorphoSys AG (MOR)
17.89
+0.02
(+0.11%)
USD |
NASDAQ |
May 03, 16:00
17.90
+0.01
(+0.06%)
After-Hours: 20:00
MorphoSys Cash and Short Term Investments (Quarterly): 754.72M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 754.72M |
| June 30, 2023 | 730.04M |
| March 31, 2023 | 863.06M |
| December 31, 2022 | 972.85M |
| June 30, 2022 | 759.24M |
| March 31, 2022 | 954.81M |
| December 31, 2021 | 1.125B |
| September 30, 2021 | 1.340B |
| March 31, 2021 | 1.316B |
| December 31, 2020 | 1.341B |
| September 30, 2020 | 926.91M |
| June 30, 2020 | 967.36M |
| March 31, 2020 | 1.148B |
| December 31, 2019 | 305.25M |
| September 30, 2019 | 423.92M |
| June 30, 2019 | 385.92M |
| March 31, 2019 | 376.65M |
| December 31, 2018 | 410.62M |
| September 30, 2018 | 499.68M |
| June 30, 2018 | 429.65M |
| March 31, 2018 | 352.31M |
| December 31, 2017 | 194.38M |
| September 30, 2017 | 196.63M |
| June 30, 2017 | 157.00M |
| March 31, 2017 | 200.12M |
| Date | Value |
|---|---|
| December 31, 2016 | 153.37M |
| September 30, 2016 | 166.07M |
| June 30, 2016 | 178.82M |
| March 31, 2016 | 252.77M |
| December 31, 2015 | 206.60M |
| September 30, 2015 | 154.51M |
| June 30, 2015 | 168.38M |
| March 31, 2015 | 146.90M |
| December 31, 2014 | 177.95M |
| September 30, 2014 | 218.75M |
| June 30, 2014 | 339.69M |
| March 31, 2014 | 346.67M |
| December 31, 2013 | 376.01M |
| September 30, 2013 | 407.74M |
| June 30, 2013 | 190.67M |
| March 31, 2013 | 208.11M |
| December 31, 2012 | 160.55M |
| September 30, 2012 | 164.63M |
| June 30, 2012 | 54.40M |
| March 31, 2012 | 50.96M |
| December 31, 2011 | 175.31M |
| September 30, 2011 | 87.59M |
| June 30, 2011 | 85.65M |
| March 31, 2011 | 71.38M |
| December 31, 2010 | 58.68M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
305.25M
Minimum
Dec 2019
1.341B
Maximum
Dec 2020
894.58M
Average
940.86M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Incyte Corp | 3.851B |
| Novartis AG | 9.694B |
| Immatics NV | 470.78M |
| Affimed NV | 80.58M |
| InflaRx NV | 99.79M |